EVOK News and Press, Evoke Pharma Inc. From 06/15/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Robinhood ( HOOD ) is falling alongside a new analyst rating. This comes from Atlantic Equities analyst John Heagerty. He dropped the stock to “underweight” with a $5 price target. Source: mund...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evoke Pharma ( EVOK ) stock is taking off on GIMOTI nasal spray news. It’s been approved for the Florida Medicaid Preferred Drug List. This has EVOK seeing heavy trading today. Source: Alliance Images...

Gainers: Evoke Pharma EVOK +52%. Zynerba Pharmaceuticals (ZYNE) +18%. LifeMD (LFMD) +13%. Vivos Therapeutics (VVOS) +12%. ACADIA Pharmaceuticals ACAD +11%. Losers: 180 Life Sciences (ATNF) -31%. Belite Bio (BLTE) -19%. VectivBio VECT -14%...

Sidus Space (SIDU) +86% on NASA’s $3.5 Billion exploration extravehicular activity services contract. Evoke Pharma (EVOK) +68% on approval for nasal spray Gimoti being added to Florida's Medicaid program Boxed (BOXD) +33%. ACADIA Pharmaceuticals (ACAD) +29% as FDA posts ...

Shares of micro-cap company Evoke Pharma (NASDAQ:EVOK) soared ~70% to $3.45 in Wednesday premarket trading, after it said it had got approval for its Gimoti nasal spray treatment for diabetic gastroparesis to be added to the Florida Medicaid Preferred Drug List (PDL), effe...

SOLANA BEACH, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that the Florida Me...

Evoke Pharma (NASDAQ:EVOK) has regained compliance with the Nasdaq minimum bid price continued listing requirement and the matter is now closed. As previously disclosed, in early May, the Company utilized its “at-the-market” program to raise proceeds of ~$7.1M, net of commission...

SOLANA BEACH, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that it received wr...

Gainers: Lixiang Education Holding (LXEH) +62%. GeoVax Labs (GOVX) +50%. Sonder Holdings (SOND) +30%. O2Micro International (OIIM) +30%. Evolving Systems (OTC:EVOL) +28%. GoldMining (GLDG) +27%. Neonode (NEON) +24%. Mesa Royalty Trust (MTR) +24%. TRxADE HEALTH (MEDS) +23%. Losers: HIVE Blockc...

Gainers: GeoVax Labs GOVX +39%. Entasis Therapeutics ETTX +21%. Allarity Therapeutics (ALLR) +14%. Tonix Pharmaceuticals (TNXP) +13%. TRxADE HEALTH (MEDS) +13%. Losers: Nymox Pharmaceutical NYMX -67%. Evoke Pharma EVOK -21%. NanoViricides...